Related Experiment Videos
Liposomes coated with chemically modified dextran interact with human endothelial cells
M Cansell1, C Parisel, J Jozefonvicz
1LRM, CNRS UMR 7540, Institut Galilée, University Paris XIII, Av. J. B. Clément, 93430 Villetaneuse, France.
Journal of Biomedical Materials Research
|July 9, 1999
Summary
Functionalized dextran-coated liposomes show enhanced uptake by human endothelial cells, indicating potential for targeted drug delivery to vascular cells.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cell Biology
Background:
- Liposomes are increasingly used in clinical settings, with ongoing research focused on targeted applications in medicine and biology.
- Vascular cell interaction with liposomes is crucial for targeted drug delivery, necessitating strategies to enhance liposome-endothelial cell interactions.
Purpose of the Study:
- To prepare and evaluate liposomes coated with functionalized dextran (FDx) for enhanced interaction with human endothelial cells.
- To investigate the role of dextran coating in liposome uptake by vascular cells for potential drug delivery applications.
Main Methods:
- Liposomes composed of phosphatidylcholine, phosphatidylethanolamine, and cholesterol were prepared using detergent dialysis.
- Liposomes were coated with hydrophobized dextran (Dx) or functionalized dextran (FDx) using a cholesterol anchor.
- Liposome uptake by human endothelial cells was quantified using radiolabeled lipids (3H-cholesterol, 14C-PC) and observed via fluorescence microscopy.
Main Results:
- FDx-coated liposomes exhibited preferential uptake by human endothelial cells compared to uncoated or Dx-coated liposomes.
- Calcium addition (up to 10 mM) significantly enhanced the uptake of FDx-coated liposomes by endothelial cells.
- Fluorescence microscopy confirmed intracellular localization of FDx-coated liposomes within the endocytotic pathway.
Conclusions:
- Coating liposomes with functionalized dextran promotes specific interactions with human endothelial cells.
- These functionalized dextran-coated liposomes represent a promising strategy for developing drug delivery vehicles targeting vascular cells.